Galderma Group AG
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
- Conditions
- Interventions
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 1075
- Registration Number
- NCT00598832
- Locations
- 🇨🇦
Lynderm Research, Inc., Markham, Ontario, Canada
🇺🇸Central Dermatology, PC, Saint Louis, Missouri, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
Treatment of Patients With Blepharitis and Facial Rosacea
- Conditions
- Interventions
- First Posted Date
- 2007-11-20
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 70
- Registration Number
- NCT00560703
- Locations
- 🇺🇸
Tanner Clinic, Layton, Utah, United States
🇺🇸Anita Nevyas-Wallace, MD, Bala-Cynwyd, Pennsylvania, United States
🇺🇸Kentucky Lions Eye Center, Louisville, Kentucky, United States
Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Registration Number
- NCT00535080
Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma
- First Posted Date
- 2007-07-12
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 340
- Registration Number
- NCT00500162
- Locations
- 🇧🇷
UNIFESP - Universidade Federal de São Paulo, Sao Paulo, Brazil
🇲🇽Hospital General de México - Servicio de Dermatología, Mexico City, Mexico
Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 102
- Registration Number
- NCT00473343
- Locations
- 🇦🇺
Department of Dermatology, St. George Hospital, Kogarah, New South Wales, Australia
🇦🇺Dermatology Department, The Queen Elisabeth Hospital, Adelaide, South Australia, Australia
🇦🇺Department of Dermatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma
- Conditions
- Interventions
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 20
- Registration Number
- NCT00472966
- Locations
- 🇺🇸
Skin Care Research, Inc., Boca Raton, Florida, United States
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 66
- Registration Number
- NCT00472043
- Locations
- 🇦🇺
Department of Dermatology, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
🇦🇺Fremantle Dermatology, Fremantle, Western Australia, Australia
🇦🇺Dept. of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 65
- Registration Number
- NCT00472108
- Locations
- 🇺🇸
Texas Dermatology Research Institute, Dallas, Texas, United States
🇺🇸Department of Dermatology, Roswell Park Cancer Institue, Buffalo, New York, United States
🇺🇸Department of Dermatology, University of Minnesota Hospital and Clinic, Minneapolis, Minnesota, United States
PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer
- Conditions
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 81
- Registration Number
- NCT00472459
- Locations
- 🇩🇪
Hautklinik Linden, Hannover, Germany
🇩🇪Klinik für Dermatologie, Venerologie und Allergologie, Campus Charité Mitte, Berlin, Germany
🇸🇪Department of Dermatology, Sahlgrenska University Hospital, Gothenburg, Sweden
Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 120
- Registration Number
- NCT00469417
- Locations
- 🇮🇹
Spedali di Brescia, Brescia, Italy
🇫🇷Hôpital Sainte-Marguerite, Marseille, France
🇫🇷Service de Dermatologie, C.H.U Saint Louis, Paris, France